Yamauchi H, Toi M, Takayama S, Nakamura S, et al. Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial. Breast Cancer 2023 Apr 1. doi: 10.1007/s12282-023-01451.
PMID: 37005966